tiprankstipranks
Kalaris Therapeutics (KLRS)
NASDAQ:KLRS
US Market
Want to see KLRS full AI Analyst Report?

Kalaris Therapeutics (KLRS) Technical Analysis

375 Followers

Technical Sentiment

Overall Consensus
Strong Sell
2Bullish
5Neutral
15Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Kalaris Therapeutics’s (KLRS) Moving Averages Convergence Divergence (MACD) indicator is -0.43, suggesting Kalaris Therapeutics is a Sell.
Kalaris Therapeutics’s (KLRS) 20-Day exponential moving average is 5.25, while Kalaris Therapeutics’s (KLRS) share price is $6.32, making it a Sell.
Kalaris Therapeutics’s (KLRS) 50-Day exponential moving average is 6.13, while Kalaris Therapeutics’s (KLRS) share price is $6.32, making it a Sell.

Kalaris Therapeutics (KLRS) Pivot Points

May 21, 2026, 10:57 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.36
4.49
4.59
4.72
4.82
4.95
5.06
Fibonacci
4.49
4.57
4.63
4.72
4.81
4.86
4.95
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Kalaris Therapeutics (KLRS) Moving Averages

May 21, 2026, 10:57 AM
Period
Simple
Exponential
MA5
4.88Sell
4.83Sell
MA10
4.90Sell
4.95Sell
MA20
5.26Sell
5.25Sell
MA50
6.10Sell
6.13Sell
MA100
7.75Sell
6.66Sell
MA200
6.49Sell
5.77Sell
Kalaris Therapeutics’s (KLRS) 10-Day exponential moving average is 4.95, while Kalaris Therapeutics’s (KLRS) share price is $6.32, making it a Sell.
Kalaris Therapeutics’s (KLRS) 100-Day exponential moving average is 6.66, while Kalaris Therapeutics’s (KLRS) share price is $6.32, making it a Sell.
Kalaris Therapeutics’s (KLRS) stock price is $6.32 and Kalaris Therapeutics’s (KLRS) 50-day simple moving average is 6.10, creating a Sell signal.
Kalaris Therapeutics’s (KLRS) stock price is $6.32 and Kalaris Therapeutics’s (KLRS) 100-day simple moving average is 7.75, creating a Sell signal.
Kalaris Therapeutics’s (KLRS) stock price is $6.32 and Kalaris Therapeutics’s (KLRS) 200-day simple moving average is 6.49, creating a Sell signal.

Kalaris Therapeutics (KLRS) Technical Indicators

May 21, 2026, 10:57 AM
Name
Value
Implied Action
RSI (14)
37.05
Neutral
STOCH (9,6)
27.30
Neutral
STOCHRSI (14)
19.64
Buy
MACD (12,26)
-0.43
Sell
ADX (14)
29.51
Neutral
Williams %R
-73.91
Buy
CCI (14)
-85.04
Neutral
ATR (14)
0.42
-
Ultimate Oscillator
50.74
Neutral
ROC
-12.50
Sell
Kalaris Therapeutics’s (KLRS) Relative Strength Index (RSI) is 37.05, creating a Neutral signal.
Kalaris Therapeutics’s (KLRS) Trend Strength Indicator (ADX) is 29.51, creating a Neutral signal.
Kalaris Therapeutics’s (KLRS) Commodity Channel Index (CCI) is -85.04, creating a Neutral signal.
Kalaris Therapeutics’s (KLRS) Price Rate of Change (ROC) is -12.50, creating a Sell signal.

FAQ

Is KLRS a Buy, Hold, or Sell?
Based on KLRS’s technical indicators, KLRS is a Strong Sell.
    What is KLRS’s RSI (14)?
    KLRS’s RSI (14) is 37.05, which suggests KLRS is a Neutral.
      What is KLRS’s MACD?
      KLRS’s MACD is -0.43, which suggests KLRS is a Sell.
        What is KLRS’s 5-day moving average?
        KLRS’s 5-day moving average is 4.88, which suggests KLRS is a Sell.
          What is KLRS’s 20-day moving average?
          KLRS 20-day moving average is 5.26, which suggests KLRS is a Sell.
            What is KLRS’s 50-day moving average?
            KLRS’s 50-day moving average is 6.10, which suggests KLRS is a Sell.
              What is KLRS’s 200-day moving average?
              KLRS’s 200-day moving average is 6.49, which suggests KLRS is a Sell.
                What is KLRS’s Williams % R (14)?
                KLRS’s Williams % R (14) is -73.91, which suggests KLRS is a Buy.
                  What is KLRS’s CCI (14)?
                  KLRS’s CCI (14) is -85.04, which suggests KLRS is a Neutral.